Badgley Phelps Wealth Managers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Badgley Phelps Wealth Managers's PFE Position: Q2 2026 in Review
Badgley Phelps Wealth Managers reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $28.5K and leaving 56,083 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #185.
Badgley Phelps Wealth Managers first reported a position in PFE in Q3 2021 and has held it in 20 quarters since. The position peaked at $20M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Badgley Phelps Wealth Managers held 56,083 shares of Pfizer worth $1.35M as of Q2 2026.
- Badgley Phelps Wealth Managers sold 1,089 Pfizer shares in Q2 2026, an estimated $28.5K.
- Pfizer made up 0.02% of Badgley Phelps Wealth Managers's portfolio in Q2 2026, its #185 holding.
- Badgley Phelps Wealth Managers first reported a position in Pfizer in Q3 2021 and has held it in 20 quarters since.
- Badgley Phelps Wealth Managers's Pfizer position peaked at $20M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Badgley Phelps Wealth Managers's 13F filing for Q2 2026, filed 31 Jul 2026.